Answers are grounded in this paper and cite their sources.
Immunophenotyping improves differential diagnosis in multiple sclerosis, suggesting better treatment strategies.
Immunophenotyping enables increasingly precise characterization of Multiple sclerosis immuno-pathogenesis. While not yet routine, these tools show promise for improving differential diagnosis, individualizing therapy initiation and monitoring. Ongoing research and standardization are paving the way towards precision immunology-approaches in clinical practice.
No takes yet. Share an insight, caveat, or question.
Möllenkamp et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: